Trial Profile
Sertraline in the Treatment of Generalized Social Phobia with Comorbidity.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 26 Mar 2018
Price :
$35
*
At a glance
- Drugs Sertraline (Primary)
- Indications Social phobia
- Focus Therapeutic Use
- 20 Mar 2018 Status changed from active, no longer recruiting to discontinued as the study drug could not be re-supplied.
- 21 Mar 2017 Planned End Date changed from 1 Mar 2017 to 1 Mar 2018.
- 21 Mar 2017 Planned primary completion date changed from 1 Jan 2017 to 1 Jan 2018.